2nd Quarter - Report
POLICY DIRECTIONS INC. for ADVANCED LIFE SCIENCES
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
FDA regulatory pathway for new antibiotic medicines. HR 2400, Strategies to Address Antimicrobial Resistance Act, portions related to introduction of and regulatory policy of new antimicrobial candidates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANKIE L TRULL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.